COMMUNIQUÉS West-GlobeNewswire

AB Science annonce le succès d’un placement prive de 3,2 millions d’euros
29/04/2026
COMMUNIQUE DE PRESSE AB SCIENCE ANNONCE LE SUCCES D’UN PLACEMENT PRIVE DE 3,2 MILLIONS D’EUROS Paris, 29 avril 2026, 8h AB Science S.A. (la “ Société ” ou “ AB Science ”, Euronext – FR0010557264 – AB) annonce aujourd' [...]
Angelini Ventures Invests in Hypervision Surgical’s £17 Million Series A to Advance Real-time Hyperspectral Imaging and Improve Clinical Outcomes in Surgery
29/04/2026
Funding will support commercial deployment, clinical adoption and further development and enhancement of the Hyperspectral Intelligence® platform for AI-assisted surgery Angelini Ventures Managing Director Tanja Dowe [...]
AB Science announces the successful completion of a EUR 3.2 million private placement
29/04/2026
PRESS RELEASE AB SCIENCE ANNOUNCES THE SUCCESSFUL COMPLETION OF A EUR 3.2 MILLION PRIVATE PLACEMENT Paris, April 29, 2026, 8am AB Science S.A. (the “ Company ” or “ AB Science ”, Euronext – FR0010557264 – AB) announces [...]
Oruka Therapeutics Announces Pricing of Upsized $700 Million Underwritten Public Offering
29/04/2026
MENLO PARK, Calif., April 28, 2026 (GLOBE NEWSWIRE) -- Oruka Therapeutics, Inc. (Nasdaq: ORKA), a clinical-stage biopharmaceutical company focused on developing novel monoclonal antibody therapeutics for psoriasis and [...]
Mesoblast Achieves Patient Recruitment Target in Pivotal Phase 3 Trial for Chronic Low Back Pain
29/04/2026
NEW YORK, April 28, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that its pivotal Phase 3 clinical trial [...]
InnoCare Announces First Patient Dosed in Phase III Trial of Orelabrutinib for SLE
29/04/2026
BEIJING, April 28, 2026 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 9969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that the first [...]
ARCPOINT ANNOUNCES RESIGNATION OF BOARD MEMBER
29/04/2026
Greenville, South Carolina, April 28, 2026 (GLOBE NEWSWIRE) -- ARCpoint Inc. (TSXV: ARC) (the “ Company ” or “ ARCpoint ”) reports that Felix Mirando has resigned as a member of the Company’s Board of Directors for [...]
Design Therapeutics Announces First Quarter 2026 Financial Results and Recent Business Updates
28/04/2026
Additional Detail Provided for RESTORE-FA (DT-216P2) Trial Design, Dosing and Endpoints David Shapiro, M.D., Appointed to Board of Directors, Strengthening Clinical and Regulatory Expertise Cash and Securities of $222.8 [...]
Galapagos’ Shareholders Adopt All Resolutions Proposed by the Board of Directors at the Annual and Extraordinary Shareholders’ Meetings 2026
28/04/2026
Mechelen, Belgium; April 28, 2026, 22:01 CET — Galapagos NV (Euronext & NASDAQ: GLPG) today announces that all resolutions proposed at the Company’s Annual and Extraordinary Shareholders’ Meetings (AGM and EGM) held [...]
Glass House Brands Reports Preliminary Unaudited First Quarter Financial Results, Updates FY2026 Guidance and Schedules Earnings Conference Call
28/04/2026
LONG BEACH, Calif. and TORONTO, April 28, 2026 (GLOBE NEWSWIRE) -- Glass House Brands Inc. ("Glass House") (CBOE CA: GLAS.A.U) (CBOE CA: GLAS.WT.U) (OTCQX: GLASF) (OTCQX: GHBWF) today announced preliminary and unaudited [...]
Myriad Genetics to Release First Quarter 2026 Financial Results on May 5, 2026
28/04/2026
SALT LAKE CITY, April 28, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. , (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, will hold its first quarter 2026 earnings conference call at 4: [...]
OPKO Health Reports First Quarter 2026 Business Highlights and Financial Results
28/04/2026
Conference call begins at 4:30 p.m. Eastern time today MIAMI, April 28, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) (OPKO) reports business highlights and financial results for the three months ended March [...]
Surrozen Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
28/04/2026
SOUTH SAN FRANCISCO, Calif., April 28, 2026 (GLOBE NEWSWIRE) -- Surrozen, Inc. (“Surrozen” or the “Company”) (Nasdaq: SRZN), a biotechnology company pioneering targeted therapeutics to harness the power of Wnt signaling [...]
ASAP Dental Care Sets New Benchmark in Clinical Excellence with Over 229,000 Successful Procedures Performed
28/04/2026
North Florida's Leading Dental Provider Offers an Increased Number of Procedures Across All Locations Jacksonville, FL, April 28, 2026 (GLOBE NEWSWIRE) -- ASAP Dental Care, a cornerstone of the Jacksonville healthcare [...]
Glass House Brands Announces Warrant Redemption Notice
28/04/2026
LONG BEACH, Calif. and TORONTO, April 28, 2026 (GLOBE NEWSWIRE) -- Glass House Brands Inc. ("Glass House") (CBOE CA: GLAS.A.U) (CBOE CA: GLAS.WT.U) (OTCQX: GLASF) (OTCQX: GHBWF) today announced that it has delivered a [...]
Trevi Therapeutics to Report First Quarter 2026 Financial Results and Provide a Corporate Update on May 5, 2026
28/04/2026
Conference call and webcast to be held at 4:30 p.m. ET NEW HAVEN, Conn., April 28, 2026 (GLOBE NEWSWIRE) -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the [...]
Pacira BioSciences Files Definitive Proxy Materials and Mails Letter to Shareholders
28/04/2026
Urges Stockholders to Vote “FOR” Pacira’s Highly Qualified Nominees on the BLUE Proxy Card Today Strongly Opposes the Election of Each of DOMA’s Underqualified Nominees BRISBANE, Calif., April 28, 2026 (GLOBE NEWSWIRE [...]
Cardiff Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
28/04/2026
SAN DIEGO, Calif., April 28, 2026 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, [...]
Carlsmed, Inc. To Participate in Upcoming Investor Conferences
28/04/2026
CARLSBAD, Calif., April 28, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), today announced that Mike Cordonnier, Chairman and Chief Executive Officer, will participate in the [...]

Pages